FDA label
What is Jublia used for?
Jublia contains efinaconazole. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “JUBLIA (efinaconazole) topical solution, 10% is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Jublia?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Jublia, solution
Indications and Usage, quoted from the label by Bausch Health US LLC (NDA203567). Cross-references to other label sections are left out.
JUBLIA (efinaconazole) topical solution, 10% is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Source: DailyMed label, set id 922d4d25-c530-11e1-9b21-0800200c9a66, version 21, effective July 1, 2025. NDC 0187-5400, one of 1 listing for this product.
Questions
What is Jublia used for?
The FDA label says: “JUBLIA (efinaconazole) topical solution, 10% is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.”
What drug class is Jublia?
FDA lists efinaconazole in the Azole Antifungal established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.